This inventor holds 2 USPTO granted patents. Top assignees: Fondazione Centro San Raffaele Del Monte Tabor, Other. Active years: 2002-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 15 
1 out of 834,601 Years Active: 2002-2010
Title: Nicolai Sidenius: Innovator in Antibody and Peptide Research
Introduction
Nicolai Sidenius is a prominent inventor based in Milan, Italy. He has made significant contributions to the fields of biochemistry and molecular biology, particularly in the development of antibodies and peptides for therapeutic applications. With a total of 2 patents, his work focuses on innovative solutions for medical challenges.
Latest Patents
Nicolai Sidenius holds two notable patents. The first patent is for an antibody against uPA/uPAR, which relates to the anti-HIV action of uPAR-activators or activated uPAR molecules. This invention also addresses the control of chemotaxis and cell migration by agents that interfere with uPAR activation. It includes methods for determining activated uPAR forms and the use of agents that disrupt the uPA/uPAR interaction for diagnosing or treating diseases. The second patent involves a uPAR mimicking peptide, which comprises the SRSRY sequence derived from the uPAR (urokinase receptor). These peptides exhibit chemotactic activity, making them useful for preventing or activating cell migration in mammals. They are particularly beneficial for treating cancer, autoimmune diseases, hyperinflammatory diseases, and for stimulating wound healing.
Career Highlights
Throughout his career, Nicolai has worked with various organizations, including the Fondazione Centro San Raffaele Del Monte Tabor. His research has led to advancements in understanding the mechanisms of cell migration and the development of therapeutic agents.
Collaborations
Nicolai has collaborated with notable colleagues such as Massimo Resnati and Francesco Blasi. Their combined expertise has contributed to the success of his research endeavors.
Conclusion
Nicolai Sidenius is a distinguished inventor whose work in antibody and peptide research has the potential to impact the treatment of various diseases. His innovative patents reflect his commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile